More cattle-derived materials used in the production of medical
products are due to be banned in the US Food and Drug
Administration's (FDA) latest steps to protect against mad cow
disease.
UK-based Stanelco says it has developed a starch-based alternative
to gelatine hardshell capsules that could also offer cost benefits
for dietary supplement makers.